Literature DB >> 25293810

Combined impact of high body mass index and in vitro fertilization on preeclampsia risk: a hospital-based cohort study.

Natalie Dayan1, Louise Pilote, Lucie Opatrny, Olga Basso, Carmen Messerlian, Amira El-Messidi, Stella S Daskalopoulou.   

Abstract

OBJECTIVES: Overweight and obese women may be heavy users of in vitro fertilization (IVF) owing to obesity-related oligo-anovulation. The higher doses of gonadotropins required to achieve pregnancy in obese women may contribute to impaired placentation and the development of preeclampsia. This study was designed to assess the combined effect of high maternal body mass index (BMI) and IVF on risk of preeclampsia and to evaluate for an interaction between the two factors.
METHODS: This is a hospital-based cohort study of 10,013 singleton pregnancies that delivered from 2001 to 2008 at a tertiary hospital in Montreal, Canada. The combined effect of high BMI and IVF on preeclampsia versus no risk factors was estimated in multivariate logistic regression models fitted with an interaction term between high BMI (> 25 or > 30 kg/m(2) ) and IVF.
RESULTS: IVF pregnancies in obese women had a considerably higher risk of preeclampsia than spontaneous nonobese pregnancies (OR 6.7, 95% CI 3.3-13.8; p interaction 0.03). IVF was not independently associated with preeclampsia (OR 0.6, 95% CI 0.3-1.4). Analyses were similar in subgroup analyses and in analyses correcting for bias.
CONCLUSIONS: High BMI is strongly associated with preeclampsia, and this risk is compounded in IVF pregnancies.
© 2014 The Obesity Society.

Entities:  

Mesh:

Year:  2014        PMID: 25293810     DOI: 10.1002/oby.20896

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Association between in vitro fertilization and ischemic placental disease by gestational age.

Authors:  Katherine M Johnson; Michele R Hacker; Kim Thornton; Brett C Young; Anna M Modest
Journal:  Fertil Steril       Date:  2020-07-22       Impact factor: 7.329

3.  Risk of ischemic placental disease in fresh and frozen embryo transfer cycles.

Authors:  Katherine M Johnson; Michele R Hacker; Nina Resetkova; Barbara O'Brien; Anna M Modest
Journal:  Fertil Steril       Date:  2019-02-28       Impact factor: 7.329

4.  Placental Vascular Calcification and Cardiovascular Health: It Is Time to Determine How Much of Maternal and Offspring Health Is Written in Stone.

Authors:  Mary C Wallingford; Ciara Benson; Nicholas W Chavkin; Michael T Chin; Martin G Frasch
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.755

5.  Association Between Pre-Pregnancy Body Mass Index and Maternal and Neonatal Outcomes of Singleton Pregnancies After Assisted Reproductive Technology.

Authors:  Hanxiang Sun; Yang Liu; Shijia Huang; Xiaosong Liu; Guohua Li; Qiaoling Du
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-13       Impact factor: 5.555

Review 6.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.

Authors:  Emily Bartsch; Karyn E Medcalf; Alison L Park; Joel G Ray
Journal:  BMJ       Date:  2016-04-19

Review 7.  What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.

Authors:  Jenny E Myers
Journal:  Placenta       Date:  2017-08-24       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.